OMT Capital Management’s Idexx Laboratories IDXX Stock Holding History

OMT Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$496K	Buy	+6,800	New	+$485K	0.94%	28

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

OMT Capital Management's IDXX Position: Q4 2015 in Review

OMT Capital Management opened a new position in Idexx Laboratories (IDXX) in Q4 2015: 6,800 shares worth $496K. The stake represents 0.94% of the portfolio and ranks #28 among its holdings.

350 funds tracked by Wall St. Rank hold IDXX as of Q4 2015.

OMT Capital Management held 6,800 shares of Idexx Laboratories worth $496K as of Q4 2015.
Idexx Laboratories was a new OMT Capital Management position in Q4 2015.
Idexx Laboratories made up 0.94% of OMT Capital Management's portfolio in Q4 2015, its #28 holding.
350 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2015.

Based on OMT Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.